Houman D. Hemmati

Director/Board Member at

Mediprint Ophthalmics, Inc.

Health Technology

Consumer Services

Finance

Profile

Houman D.
Hemmati is currently a Director at Noveome Biotherapeutics, Inc. and also holds Director positions at Trailhead Biosystems, Inc. and Mediprint Ophthalmics, Inc. Previously, he was an Advisor at Draper Fisher Jurvetson ePlanet Ventures, a Research Analyst at Griffen-Rose LLC, and a Vice President-Medical & Clinical Development at Capricor Therapeutics, Inc. Hemmati received his undergraduate degree from Stanford University and his doctorate degrees from the University of California, Los Angeles and the California Institute of Technology.

Houman D. Hemmati active positions

Companies	Position	Start
Mediprint Ophthalmics, Inc. Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care	Director/Board Member	-
Trailhead Biosystems, Inc. Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies	Director/Board Member	-
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Director/Board Member	15/11/2022

All active positions of Houman D. Hemmati

Former positions of Houman D. Hemmati

Companies	Position	End
Draper Fisher Jurvetson ePlanet Ventures Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors.	Corporate Officer/Principal	-
CAPRICOR THERAPEUTICS, INC.	Corporate Officer/Principal	-
Griffen-Rose LLC Griffen-Rose LLC Investment ManagersFinance Provides investment research	Analyst-Equity	-

See the detail of Houman D. Hemmati's experience

Training of Houman D. Hemmati

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Houman D. Hemmati's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Draper Fisher Jurvetson ePlanet Ventures Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors.	Finance
Griffen-Rose LLC Griffen-Rose LLC Investment ManagersFinance Provides investment research	Finance
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Health Technology
Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases	Health Technology
Trailhead Biosystems, Inc. Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies	Health Technology
Mediprint Ophthalmics, Inc. Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care	Health Technology